Spyre Therapeutics, Inc. - Common Stock (SYRE)
CUSIP: 00773J202
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 78,841,667
- Total 13F shares
- 63,624,754
- Share change
- +1,349,292
- Total reported value
- $952,552,077
- Put/Call ratio
- 57%
- Price per share
- $14.97
- Number of holders
- 128
- Value change
- +$19,485,332
- Number of buys
- 80
- Number of sells
- 42
Quarterly Holders Quick Answers
What is CUSIP 00773J202?
CUSIP 00773J202 identifies SYRE - Spyre Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00773J202:
Institutional Holders of Spyre Therapeutics, Inc. - Common Stock (SYRE) as of Q2 2025
As of 30 Jun 2025,
Spyre Therapeutics, Inc. - Common Stock (SYRE) was held by
128 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,624,754 shares.
The largest 10 holders included
FMR LLC, Fairmount Funds Management LLC, BlackRock, Inc., RTW INVESTMENTS, LP, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, VR ADVISER, LLC, BRAIDWELL LP, Capital International Investors, and Driehaus Capital Management LLC.
This page lists
128
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
128
Q2 2025 holders
128
Holder diff
0
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.